FDA clearance for Binax Bacterial Meningitis
go back to news archivesBinax have announced an additional cleared application for the patented Streptococcus pneumoniae Antigen Test.
The test can be used on CSF for the detection of bacterial meningitis caused by S. pneumoniae
Binax recently announced an exclusive distribution partnership with Remel Inc to provide rapid tests to hospital and clinical reference laboratories in the USA.
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : Binax, Inc. [USA]
Now part of Alere, Inc View Company Information
Posted on December 15, 2001
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
Unmasking Endotoxins: A Sample Preparation Strategy to Overcome LER
-
Next-Generation MAT vs. Traditional Pyrogen Tests: Faster, Ethical, and More Reliable
-
LIMS Launchpad Series: Episode #1 - Strategic Planning
-
Navigating Nitrosamine Challenges: From Risk Assessment to Enhanced Ames Testing and Analytics
-
IAFP 2025
-
ADLM 2025
-
Food Safety Culture Workshop
-
Who are the "Real" Spoilers in Food?
-
CPD accredited course: Level 3 HACCP & Food Safety
-
Culture Eats HACCP for Breakfast (free)
